Literature DB >> 33959979

The potential role of nucleophosmin (NPM1) in the development of cancer.

Fateme Karimi Dermani1,2, Saeideh Gholamzadeh Khoei1,3, Saeid Afshar1, Razieh Amini1.   

Abstract

Nucleophosmin (NPM1) is a well-known nucleocytoplasmic shuttling protein that performs several cellular functions such as ribosome biogenesis, chromatin remodeling, genomic stability, cell cycle progression, and apoptosis. NPM1 has been identified to be necessary for normal cellular functions, and its altered regulation by overexpression, mutation, translocation, loss of function, or sporadic deletion can lead to cancer and tumorigenesis. In this review, we focus on the gene and protein structure of NPM1 and its physiological roles. Finally, we discuss the association of NPM1 with various types of cancer including solid tumors and leukemia.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  NPM1; cancer; leukemia; nucleophosmin; solid tumors; tumorigenesis

Mesh:

Substances:

Year:  2021        PMID: 33959979     DOI: 10.1002/jcp.30406

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity.

Authors:  Qiankun Luo; Yanfeng Pan; Qiang Fu; Xu Zhang; Shuai Zhou; Pengfei Yu; Huiyuan Tian; Pan Liu; Song Chen; Hongwei Zhang; Tao Qin
Journal:  Cell Biol Toxicol       Date:  2022-02-10       Impact factor: 6.691

2.  Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.

Authors:  Raphaël Bonnet; Lee Mariault; Jean-François Peyron
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

3.  NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma.

Authors:  Yangfan Zhou; Yuan Fang; Junjie Zhou; Yulian Liu; Shusheng Wu; Bin Xu
Journal:  Front Genet       Date:  2021-11-26       Impact factor: 4.599

4.  CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL.

Authors:  Antonin Bouroumeau; Lucile Bussot; Sieme Hamaidia; Andrea Garcìa-Sandoval; Anna Bergan-Dahl; Patricia Betton-Fraisse; Samuel Duley; Cyril Fournier; Romain Aucagne; Annie Adrait; Yohann Couté; Anne McLeer; Edwige Col; Laurence David-Boudet; Tatiana Raskovalova; Marie-Christine Jacob; Claire Vettier; Simon Chevalier; Sylvain Carras; Christine Lefebvre; Caroline Algrin; Rémy Gressin; Mary B Callanan; Hervé Sartelet; Thierry Bonnefoix; Anouk Emadali
Journal:  Cancers (Basel)       Date:  2021-11-24       Impact factor: 6.639

5.  Nucleophosmin 1 is a prognostic marker of gastrointestinal cancer and is associated with m6A and cuproptosis.

Authors:  Xu-Sheng Liu; Chao Liu; Jing Zeng; Dao-Bing Zeng; Yi-Jia Chen; Fan Tan; Yan Gao; Xiao-Yu Liu; Yu Zhang; Yao-Hua Zhang; Zhi-Jun Pei
Journal:  Front Pharmacol       Date:  2022-09-14       Impact factor: 5.988

Review 6.  PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression.

Authors:  Yaw-Dong Lang; Yuh-Shan Jou
Journal:  J Biomed Sci       Date:  2021-08-02       Impact factor: 8.410

7.  NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.

Authors:  Xu-Sheng Liu; Lu-Meng Zhou; Ling-Ling Yuan; Yan Gao; Xue-Yan Kui; Xiao-Yu Liu; Zhi-Jun Pei
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.